Literature DB >> 33633666

Vitamin D Receptor Polymorphism and Myasthenia Gravis in Chinese Han Population.

Ji-Lan Han1,2, Yao-Xian Yue3, Xiang Gao4, Yan-Chen Xie5, Hong-Jun Hao6, Hong-Yan Li3, Xiao-Long Yu7, Jie Li3, Rui-Sheng Duan1, Hai-Feng Li8.   

Abstract

Myasthenia gravis (MG) is an autoimmune disease in which antibodies bind to acetylcholine receptors (AChR) or other functional molecules in the postsynaptic membrane at the neuromuscular junction. Vitamin D (VD) has a number of pluripotent effects, which include immune-regulation and bone metabolism. The immunomodulatory actions of 1,25(OH)2D3 are mediated by its binding to a vitamin D receptor (VDR). In the study, we undertook a case-control study to explore the association between VDR gene polymorphism and the susceptibility and severity of MG patients. Four hundred and eighty MG patients and 487 healthy controls were included and gene polymorphisms of VDR were determined with improved multiplex ligation detection reaction technique and SNPscanTM technique. MG patients were classified into subgroups by essential clinical features and by a comprehensive classification. The frequencies of alleles and genotypes were compared between the MG group and the control group, between each MG subgroup and the control group, and between each pair of MG subgroups. There were no significant differences in frequencies of alleles and genotypes between MG patients and healthy controls, between MG subgroups and healthy controls, or between each pair of MG subgroups in the analysis of subgroups classified by essential clinical features (onset age, gender, thymoma, AChRAb positivity, onset involvement) and the maximal severity (modified Oosterhuis score). In the analysis of subgroups with a comprehensive classification, the frequencies of alleles and genotypes in rs731236 showed significant differences between adult non-thymoma AChRAb negative MG subgroup and the control group, as well as the adult non-thymoma AChRAb positive MG group. In the Chinese Han population, rs731236 was found to be possibly associated with adult non-thymoma AChRAb negative MG patients, although this needs further confirmation.
Copyright © 2021 Han, Yue, Gao, Xie, Hao, Li, Yu, Li, Duan and Li.

Entities:  

Keywords:  myasthenia gravis; polymorphism; severity; susceptibility; vitamin D receptor

Year:  2021        PMID: 33633666      PMCID: PMC7900549          DOI: 10.3389/fneur.2021.604052

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  30 in total

Review 1.  Myasthenia Gravis.

Authors:  Nils E Gilhus
Journal:  N Engl J Med       Date:  2016-12-29       Impact factor: 91.245

Review 2.  Immunomodulatory and Immunosuppressive Roles of 1α,25(OH)2D3 in Autoimmune Diseases.

Authors:  H Alhassan Mohammed; A A Saboor-Yaraghi; A Mirshafiey; H Vahedi; M R Shiri-Shahsavar; A Mousavi Nasl Khameneh
Journal:  Scand J Immunol       Date:  2017-02       Impact factor: 3.487

Review 3.  Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.

Authors:  Sonia Berrih-Aknin; Rozen Le Panse
Journal:  J Autoimmun       Date:  2014-01-03       Impact factor: 7.094

Review 4.  Myasthenia gravis: subgroup classification and therapeutic strategies.

Authors:  Nils Erik Gilhus; Jan J Verschuuren
Journal:  Lancet Neurol       Date:  2015-10       Impact factor: 44.182

Review 5.  Immunomodulatory Role of Vitamin D: A Review.

Authors:  Agnieszka Skrobot; Urszula Demkow; Małgorzata Wachowska
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 6.  Vitamin D receptor 2016: novel ligands and structural insights.

Authors:  Miguel A Maestro; Ferdinand Molnár; Antonio Mouriño; Carsten Carlberg
Journal:  Expert Opin Ther Pat       Date:  2016-08-12       Impact factor: 6.674

7.  Vitamin D receptor variants and uncontrolled asthma.

Authors:  K Hutchinson; C P Kerley; J Faul; P Greally; D Coghlan; M Louw; B Elnazir; Y Rochev
Journal:  Eur Ann Allergy Clin Immunol       Date:  2017-11-28

8.  Vitamin D receptor gene polymorphisms and haplotypes in Hungarian patients with idiopathic inflammatory myopathy.

Authors:  Levente Bodoki; Ji-Qing Chen; Margit Zeher; Melinda Nagy-Vincze; Zoltán Griger; Erika Zilahi; Katalin Dankó
Journal:  Biomed Res Int       Date:  2015-01-14       Impact factor: 3.411

9.  Positive association of vitamin D receptor gene variations with multiple sclerosis in South East Iranian population.

Authors:  Mehrnaz Narooie-Nejad; Maryam Moossavi; Adam Torkamanzehi; Ali Moghtaderi
Journal:  Biomed Res Int       Date:  2015-01-20       Impact factor: 3.411

10.  Association between vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis.

Authors:  Danyal Imani; Bahman Razi; Morteza Motallebnezhad; Ramazan Rezaei
Journal:  BMC Neurol       Date:  2019-12-26       Impact factor: 2.474

View more
  2 in total

1.  Vitamin D Receptor and Binding Protein Gene Variants in Patients with Essential Tremor.

Authors:  José A G Agúndez; Elena García-Martín; Hortensia Alonso-Navarro; Christopher Rodríguez; Mónica Díez-Fairén; Ignacio Álvarez; Pau Pastor; Julián Benito-León; Tomás López-Alburquerque; Félix Javier Jiménez-Jiménez
Journal:  Mol Neurobiol       Date:  2022-03-24       Impact factor: 5.590

Review 2.  Autoimmune disease and interconnections with vitamin D.

Authors:  Jane Fletcher; Emma L Bishop; Stephanie R Harrison; Amelia Swift; Sheldon C Cooper; Sarah K Dimeloe; Karim Raza; Martin Hewison
Journal:  Endocr Connect       Date:  2022-03-31       Impact factor: 3.221

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.